Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,057.02 5.99 (0.57%) as of 4:30 Mon 7/1


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 110.66(B)
Last Volume: 383,195 Avg Vol: 759,306
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 192,108 255,165 311,759 469,743
Total Sell Value $188,697,290 $247,812,013 $294,950,701 $405,465,351
Total People Sold 7 14 16 18
Total Sell Transactions 18 43 67 128
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 2430
  Page 55 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Aberman Michael S VP Strategy and Investor Relat   •       –      –    2014-08-19 4 AS $350.00 $1,263,850 D/D (3,611) 15,600     -
   Aberman Michael S VP Strategy and Investor Relat   •       –      –    2014-08-18 4 D $351.06 $1,804,097 D/D (5,139) 19,211     -
   Aberman Michael S VP Strategy and Investor Relat   •       –      –    2014-08-18 4 OE $52.03 $455,263 D/D 8,750 24,350     -
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2014-08-18 4 AS $353.00 $2,073,875 D/D (5,875) 3,000     -
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2014-08-18 4 OE $52.03 $305,676 D/D 5,875 8,875     -
   Brown Michael S Director   –       •      –    2014-08-15 4 AS $349.20 $1,047,600 D/D (3,000) 0     -
   Brown Michael S Director   –       •      –    2014-08-15 4 OE $33.42 $100,260 D/D 3,000 3,000     -
   Goldstein Joseph L Director   –       •      –    2014-08-14 4 S $347.65 $695,300 D/D (2,000) 6,000     -
   Vagelos P Roy Chairman of the Board   •       •      –    2014-08-13 4 S $340.01 $2,729,600 D/D (8,028) 248,540     -
   Vagelos P Roy Chairman of the Board   •       •      –    2014-08-11 4 S $340.02 $3,186,967 D/D (9,372) 256,568     -
   Stahl Neil SVP Research and Development S   •       –      –    2014-08-11 4 S $339.33 $3,959,204 D/D (11,646) 13,527     -
   Vagelos P Roy Chairman of the Board   •       •      –    2014-08-08 4 S $340.33 $884,858 D/D (2,600) 265,940     -
   Stahl Neil SVP Research and Development S   •       –      –    2014-08-08 4 S $340.60 $715,340 D/D (2,100) 25,173     -
   Vagelos P Roy Chairman of the Board   •       •      –    2014-08-07 4 D $340.12 $48,518,458 D/D (142,651) 268,540     -
   Vagelos P Roy Chairman of the Board   •       •      –    2014-08-07 4 OE $9.49 $2,565,640 D/D 270,352 411,191     -
   Stahl Neil SVP Research and Development S   •       –      –    2014-08-07 4 S $340.39 $252,304 D/D (741) 27,273     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2014-08-07 4 S $338.37 $2,302,946 D/D (6,806) 15,441     -
   Stahl Neil SVP Research and Development S   •       –      –    2014-08-06 4 D $336.11 $6,894,624 D/D (20,513) 28,014     -
   Stahl Neil SVP Research and Development S   •       –      –    2014-08-06 4 OE $21.25 $743,750 D/D 35,000 48,527     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2014-08-06 4 D $336.11 $2,754,085 D/D (8,194) 22,247     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2014-08-06 4 OE $21.25 $318,750 D/D 15,000 30,441     -
   Goldstein Joseph L Director   –       •      –    2014-08-06 4 S $331.20 $662,400 D/D (2,000) 8,000     -
   Brown Michael S Director   –       •      –    2014-07-31 4 GD $0.00 $0 I/I 2,700 0     -
   Brown Michael S Director   –       •      –    2014-07-30 4 GA $0.00 $0 I/I 5,687 20,349     -
   Brown Michael S Director   –       •      –    2014-07-30 4 GD $0.00 $0 D/D 5,687 0     -
  2430 Records found
  Previous  50  51  52  53  54  55  56  57  58  59  Next   
  Page 55 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us